anti-BCMA-CAR-T
IIT2024103
Phase 2 mab active
Quick answer
anti-BCMA-CAR-T for Multiple Myeloma is a Phase 2 program (mab) at China SXT Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Multiple Myeloma
- Phase
- Phase 2
- Modality
- mab
- Status
- active